louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT01062334: Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection for Rectum Cancer
Official title: Intraperitoneal Microdialysis Monitoring of Patients During the Early Postoperative Period After LAR With Reference to Early Diagnosis of Anastomotic Leakage Ore Other Complications
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Cancer
Keywords: Anastomotic leakage after LAR
Lead sponsor: Odense University Hospital
Sponsor class: OTHER
Collaborators: name: Vejle Hospital
First posted: 2010-02-04
Enrollment: 150
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: Anastomotic leakage is a serious complication after LAR with high morbidity and mortality rates. Early diagnosis and treatment is mandatory. The primary aim of the present study is to investigate the clinical use of peritoneal microdialysis and whether is able to detect anastomotic leakage prior to clinical symptoms.

Detailed description: Patients undergoing LAR for rectum cancer is subjected to peritoneal microdialyses during the postoperative period until the 7. postoperative day. Samples are collected every 4-hour. Samples will be analyzed continuously but the results will not be included in the clinical evaluation of the patient. Before removing the microdialysis catheter a CT whit rectal enema is preformed. Every day the patient will be evaluated whit a standardised clinical scoring system with attention at anastomotic leakage.

A total of 150 patients will be included in this study. The results of the peritoneal microdialyses will be compared with the clinical scorings system in each patient. The results form the uncomplicated courses will be used to define the normal variations in peritoneal microdialysis. This will be compared to results from patients with various complications.

The study is approved by the local scientific ethical committee No. ------

Eligibility criteria: Inclusion Criteria:

* Histological verified cancer
* The cancer must be located in rectum maximum of 15 cm.
* Diverting stoma is allowed
* Perioperative radio-chemotherapy is allowed

Exclusion Criteria:

* Disseminated cancer

Primary outcomes:
measure: Significant elevated peritoneal microdialysis parameter like lactate and L/P-ratio
timeFrame: Clinically complications with in 30th days after surgery
Secondary outcomes:
Other outcomes:
Locations:
city: Odense C.
country: Denmark
facility: Odense University hospital
state: Fyn
city: Vejle
country: Denmark
facility: Vejle hospital
Study officials:
References:
Clinical trial NCT05739734: Safety of CRIS100 on Treatment Spinal Cord Injury
Official title: Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: EARLY_PHASE1
Conditions: Thoracic Spinal Cord Injury
Lead sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.
Sponsor class: INDUSTRY
First posted: 2023-02-22
Enrollment: 5
Sex: ALL
Minimum age (years): 18
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are:

* safety of CRIS100
* efficacy of CRIS100

Participants will receive 75 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.

Detailed description: Participants with complete spinal cord injury between T2 and T10 (ASIA A, according to ISNCSCI, 2019 revision) and:

* occurred less than 72 hours ago
* with surgical indication
* bulbocavernous reflex present
* who can receive treatment with CRIS100 within 72 hours after the trauma (preferably within 24 hours)

Eligibility criteria: Inclusion Criteria:

* Signature of the Free and Informed Consent Term by the participant or legal guardian
* Age between 18 and 70 years old;
* Thoracic spinal cord injury between T2 and T10, with surgical indication, occurred less than 72 hours before surgery;
* Presence of bulbo cavernosum reflex;
* Patients with a lesion classified as ASIA A according to the ISNCSCI (2019 revision);

Exclusion Criteria:

* Absence of bulbocavernous reflex up to 72 hours after the trauma.
* Presence of severe brain trauma.
* Patients with lesions above T2 or below T10.
* More than one site of spinal cord injury.
* History of alcohol or illicit drug abuse, as defined by DSM 5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition or later).
* Patients who need permanent mechanical respiratory support.
* Polytraumatized patients who, in the investigator's assessment, compromise the neurological evolution.
* Neurological diseases or functional dependence of any etiology prior to the trauma.
* Any other comorbidity that, at the discretion of the investigator, makes it impossible to include the patient in the study.

Primary outcomes:
measure: Serious adverse events (SAE)
timeFrame: 6 months
measure: Anti-drug antibodies (ADA)
timeFrame: 6 months
measure: Liver function
timeFrame: 6 months
measure: Kidney function
timeFrame: 6 months
measure: White blood cell (WBC)
timeFrame: 6 months
measure: Hemoglobin
timeFrame: 6 months
measure: Imaging exams
timeFrame: 6 months
Secondary outcomes:
measure: Efficacy of CRIS100
timeFrame: 6 months
Other outcomes:
Locations:
Study officials:
References:
Clinical trial NCT04719234: Lung Ultrasonography in COVID-19 Pneumonia
Official title: Comparison of Lung Ultrasonography Findings With Chest Computerized Tomography Results in Corona virüs (COVID-19) Pneumonia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Lung Ultrasound
Pneumonia
Covid19
Lead sponsor: Bursa Yüksek İhtisas Education and Research Hospital
Sponsor class: OTHER_GOV
First posted: 2021-01-22
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: Lung ultrasonography has been used for diagnosis and treatment in many departments including intensive care before the pandemic. The gold standard method for the diagnosis of pneumonia is still chest tomography. Ultrasonography, which has advantages over tomography, has also been tried to be used in covid 19 pneumonia.

Detailed description: In this study, it was aimed to investigate the efficiency of lung ultrasonography in diagnosis of covid 19 pneumonia.

Eligibility criteria: Inclusion Criteria:

* 18 and 85 years old
* Hospitalized in intensive care unit
* PCR tested
* Thoracic CT applied

Exclusion Criteria:

* Previous lung and thoracic wall surgery
* Anatomically with thoracic wall disorder
* Patients who did not consent to participate in the study

Primary outcomes:
measure: Relationship between Thoracic CT imaging results and LUS results
timeFrame: 6 hours
Secondary outcomes:
measure: Characteristics of lesions
timeFrame: 6 hours
Other outcomes:
measure: the relation of the lesions with the pleura
timeFrame: 6 hours
Locations:
city: Bursa
country: Turkey
facility: University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
Study officials:
affiliation: Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
name: Korgün Ökmen, Assoc. PhD.
role: PRINCIPAL_INVESTIGATOR
affiliation: Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
name: Durdu Kahraman Yıldız, M.D
role: STUDY_CHAIR
affiliation: Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
name: Emel Tatar Soyaslan, M.D
role: STUDY_CHAIR
References:
citation: Okmen K, Yildiz DK, Soyaslan E. Comparison of lung ultrasonography findings with chest computed tomography results in coronavirus (COVID-19) pneumonia. J Med Ultrason (2001). 2021 Apr;48(2):245-252. doi: 10.1007/s10396-021-01081-7. Epub 2021 Feb 26.
Clinical trial NCT01565434: Erythrocyte Complement Receptor 1 and Alzheimer Disease
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Alzheimer Disease
Lead sponsor: CHU de Reims
Sponsor class: OTHER
First posted: 2012-03-28
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Primary purpose: SCREENING

Brief summary: Main objective: investigate whether a functional polymorphism of CR1 (length, number of binding sites in C4b C3b, erythrocyte density, rate of soluble CR1 ...) so determined genetic or acquired, is a susceptibility factor for the disease Alzheimer's.


Eligibility criteria: Inclusion Criteria:

* caucasians people with a Alzheimer dementia defined on DSMIV criteria for patients and without Alzheimer disease for control subjects

Exclusion Criteria:

* diseases modifying CR1 physiology

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Reims
country: France
facility: CHU de REIMS
Study officials:
References:
Clinical trial NCT03599934: Effect of Home Exercise on Reducing Falls
Official title: The Effect of Lifestyle-integrated Functional Exercise Plus a Home Safety Visit on Reducing Falls in Community Older Fallers: a Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Fall
Keywords: Elderly
Exercise
Fall
Home safety
Lead sponsor: Chinese University of Hong Kong
Sponsor class: OTHER
First posted: 2018-07-26
Enrollment: 108
Sex: ALL
Minimum age (years): 60
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: This proposed randomized controlled trial aims to study the long-term compliance of the LiFE program and its combined effects with a home safety visit on fall prevention in community-dwelling older fallers.

Detailed description: This will be a single-blinded randomized controlled trial. The subjects will be randomly assigned to the LiFE exercise plus home safety assessment group, or the control group by a computer program operated by an independent researcher. This study conforms to the ethical principles of the World Medical Association Declaration of Helsinki.

Eligibility criteria: Inclusion Criteria:

* aged 60 or older
* able to ambulate with a Functional Ambulation Category (FAC) score ≥ 3
* able to walk for ≥ 10 meters
* history of falls in the past 12 months
* living in the community
* without MCI or dementia according to the 5-minute Montreal Cognitive assessment
* have a moderate fall risk or above as assessed by the Physiological Profile Assessment
* able to understand Chinese.

Exclusion Criteria:

* blindness
* diagnosis of mental disorders (e.g., severe depression, schizophrenia)
* any contraindications to exercise (e.g. unstable angina).

Primary outcomes:
measure: Fall
timeFrame: 1.5 years
Secondary outcomes:
measure: Handgrip strength
timeFrame: Baseline and follow-up assessment at 6-month
measure: Functional lower body strength
timeFrame: Baseline and follow-up assessment at 6-month
measure: Single leg standing balance
timeFrame: Baseline and follow-up assessment at 6-month
measure: 10-meter walk test
timeFrame: Baseline and follow-up assessment at 6-month
measure: Timed-up and Go test
timeFrame: Baseline and follow-up assessment at 6-month
measure: Timed-up and Go test with dual-task
timeFrame: Baseline and follow-up assessment at 6-month
measure: Montreal Cognitive Assessment 5-minute protocol
timeFrame: Baseline and follow-up assessment at 6-month
measure: Activity level
timeFrame: Baseline and follow-up assessment at 6-month
measure: Fall risk
timeFrame: Baseline and follow-up assessment at 6-month
Other outcomes:
Locations:
city: Hong Kong
country: Hong Kong
facility: The Chinese University of Hong Kong Jockey Club Centre of Osteoporosis Care and Control
city: Hong Kong
country: Hong Kong
facility: The Chinese University of Hong Kong
Study officials:
affiliation: The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
name: Timothy Kwok, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02775734: NAC in CC Resistant PCOS After LOD
Official title: N-acetyl-cysteine in Clomiphene Citrate Resistant Polycystic Ovary Syndrome After Laparoscopic Ovarian Drilling: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
PHASE3
Conditions: Clomiphene Citrate Resistant Polycystic Ovary Syndrome
Keywords: Polycystic Ovary Syndrome
N-acetyl-cysteine
Clomiphene citrate
Clomiphene citrate resistant
Laparoscopic ovarian drilling
therapy
Lead sponsor: Ain Shams University
Sponsor class: OTHER
First posted: 2016-05-18
Enrollment: 144
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This prospective randomized placebo-controlled double blind clinical trial will conducted in Ain Shams University maternity Hospital including 120 women diagnosed with clomiphene citrate resistant polycystic ovary syndrome. After laparoscopic ovarian drilling, they will be randomized to either receiving 50 mg oral clomiphene citrate twice daily and oral NAC 1,200 mg/day for 5 days starting from cycle day 2 to cycle day 6 (group 1 = 60 patients) or clomiphene citrate only (group 2 = 60 patients). The primary outcome will be biochemical pregnancy rate, secondary outcomes include Clinical pregnancy rate, ovulation rate, live birth rate, number of follicles ≥ 18 mm and endometrial thickness at triggering ovulation, mid- luteal sub-endometrial blood flow indices, and incidence of side effects.


Eligibility criteria: Inclusion Criteria:

* Body mass index (BMI) between 25 and 30 Kg/m 2.
* CC-resistant Polycystic ovary syndrome

Exclusion Criteria:

* • Patients with BMI under 25 or over 30 Kg/m 2.

  * Hyper or hypothyroidism, or hyperprolactinemia.
  * Current or previous (within the last six months) use of oral contraceptives, glucocorticoids, antiandrogens, antidiabetic and anti-obesity drugs or other hormonal drugs.
  * Intention to start a diet or a specific program of physical activity.
  * Organic pelvic diseases.
  * Tubal or male factor infertility.
  * Interval of earlier treatment with any of the fertility drugs of less than 6 months.
  * Contraindication to either:

    * Clomiphene citrate: liver disease, undiagnosed abnormal uterine bleeding, uterine fibroids, endometrial cancer, ovarian enlargement or hyper stimulation
    * HCG injection: ovarian enlargement or hyper stimulation

Primary outcomes:
measure: Biochemical pregnancy rate
timeFrame: 6 months
Secondary outcomes:
measure: Clinical pregnancy rate
timeFrame: 6 months
measure: Live-birth rate
timeFrame: 15 months
measure: Ovulation rate
timeFrame: 6 months
measure: follicles more than or equal 18 mm
timeFrame: 6 months
measure: Pre-ovulatory endometrial thickness
timeFrame: 6 months
measure: mid-luteal sub-endometrial doppler blood flow indices
timeFrame: 6 months
measure: Incidence of side effects
timeFrame: 6 months
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Ain Shams University Maternity Hospital
Study officials:
References:
Clinical trial NCT01513434: Femoral Tunnel Position on Conventional MRI After Anterior Cruciate Ligament Reconstruction-Transtibial Technique Versus Transportal Technique
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Anterior Cruciate Ligament Rupture
Lead sponsor: National Police Hospital
Sponsor class: OTHER_GOV
First posted: 2012-01-20
Enrollment: 64
Sex: MALE
Minimum age (years): 17
Maximum age (years): 45
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The position of the femoral tunnel in anterior cruciate ligament (ACL) reconstruction has been assessed on three dimensional CT (3D-CT) scan or in cadaveric study. However, these methods have some issues; 3D-CT scan has a concern on radiation exposure and cadaveric study is not easily available nor an in vivo test. The purpose of this study is to compare the position of the femoral tunnel aperture on conventional MRI and the outcomes after single bundle ACL reconstruction using free tendon Achilles allograft between transportal technique and transtibial technique in active young men.


Eligibility criteria: Inclusion Criteria:

* diagnosis of anterior cruciate ligament rupture

Exclusion Criteria:

* female
* over 45 years old
* the subjects who had ACL reconstruction with graft other than Achilles allograft
* the subjects who had concomitant other ligament injuries on the same knee needing surgical treatment
* revision ACL reconstruction
* double bundle ACL reconstruction
* concomitant full thickness cartilage injury needing cartilage repairing surgery

Primary outcomes:
measure: Lysholm score
timeFrame: at least two years after surgery
measure: Position of femoral tunnel aperture
timeFrame: within one week after surgery
Secondary outcomes:
Other outcomes:
Locations:
city: Seoul
country: Korea, Republic of
facility: National Police Hospital
Study officials:
References:
Clinical trial NCT01938534: Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Helicobacter Eradication
Lead sponsor: Ajou University School of Medicine
Sponsor class: OTHER
First posted: 2013-09-10
Enrollment: 440
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Prospective study : Helicobacter pylori eradication therapy in accordance with past antibiotics use.

Detailed description: Antibiotics resistant is serious problem in helicobacter pylori eradication. Clarithromycin is very important antibiotics in eradication. But clarithromycin resistance is increased. Major cause of clarithromycin resistance is past consumption of macrolide. Thus the investigators propose eradication of macrolide used group bismuth contained four drugs therapy.

Eligibility criteria: Inclusion Criteria:

* Peptic ulcer disease
* Gastric MALT lymphoma
* Early gastric cancer
* Familial history of gastric cancer
* Idiopathic iron deficiency
* Chronic idiopathic thrombocytopenia
* Atrophic gastritis
* Helicobacter infected dyspepsia
* Long term NSAIDs use

Exclusion Criteria:

* Pregnant
* Previous proton pump inhibitor, antibiotics or anticoagulant use within 2 weeks
* Previous stomach surgery
* Severe ill patients (heart failure, hepatic failure, renal failure, hematologic disorder, severe psychologic or neurologic disorder)
* Previous Helicobacter eradication
* Allergy for Helicobacter eradication medicine

Primary outcomes:
measure: Eradication rate of Helicobacter pylori
timeFrame: one month
Secondary outcomes:
Other outcomes:
Locations:
city: Suwon
country: Korea, Republic of
facility: Ajou University Hospital
Study officials:
References:
Clinical trial NCT05222334: Ultrasound-Guided Extrafascial Versus Intrafascial Interscalene Brachial Plexus Block in Shoulder Arthroscopy
Official title: Perioperative Respiratory and Analgesic Effects of Ultrasound-Guided Extrafascial Versus Intrafascial Interscalene Brachial Plexus Block in Patients Undergoing Shoulder Arthroscopy
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Arthroscopy
Analgesia
Intrafascial Interscalene Brachial Plexus Block
Lead sponsor: Tanta University
Sponsor class: OTHER
First posted: 2022-02-03
Enrollment: 50
Sex: ALL
Minimum age (years): 21
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The aim of the study is to compare the diaphragmatic excursion and postoperative analgesia in the extrafascial versus intrafascial Interscalene brachial plexus block in patients undergoing shoulder arthroscopy.


Eligibility criteria: Inclusion Criteria:

* Adult patients of both sexes aged (21-60years) with American Society of Anesthesiologists (ASA) physical status I/II scheduled for shoulder arthroscopy

Exclusion Criteria:

1. Patient refusal.
2. Pre-existing (obstructive or restrictive) pulmonary disease.
3. Bleeding disorders (coagulopathy).
4. Mental dysfunction.
5. History of allergy to local anesthetics.
6. Pregnancy
7. Body mass index (BMI) \>40

Primary outcomes:
measure: Incidence of diaphragmatic excursion reduction after interscalene block
timeFrame: 30 min postoperative.
Secondary outcomes:
measure: Efficacy of block (sensory)
timeFrame: 30 minutes Postoperatively
measure: Forced expiratory volume in 1 second (FEV 1)
timeFrame: Intraoperatively or 30 minutes postoperatively
measure: Pain score using numerical rating scale (NRS)
timeFrame: 24 hours Postoperative
measure: Total postoperative analgesic consumption
timeFrame: 24 hours Postoperative
measure: Peak expiratory flow (PEF)
timeFrame: Intraoperatively or 30 minutes postoperatively
measure: Efficacy of block (Motor)
timeFrame: 30 minutes Postoperatively
Other outcomes:
Locations:
Study officials:
References:
Clinical trial NCT01885234: Aerobic Training in Pregnant Women With Gestational Diabetes and Chronic Hypertension
Official title: Aerobic Training Effect in Pregnant Women With Gestational Diabetes and Chronic Hypertension: Randomized Clinical Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pregnancy
Gestational Diabetes Mellitus
Chronic Hypertension in Obstetric Context
Keywords: Glycated hemoglobin
HOMA
Pregnancy
aerobic exercise
Lead sponsor: Hospital de Clinicas de Porto Alegre
Sponsor class: OTHER
First posted: 2013-06-24
Enrollment: 9
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 27
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The aim of the present study is verify glycated hemoglobin (HbA1c) and HOMA behavior in pregnant women with gestational diabetes or chronic hypertension after an aerobic training in cycle-ergometer. The sample is composed by 64 pregnant and sedentary women, 20 weeks' pregnant.

Two experimental groups (gestational diabetes and chronic hypertension, n = 16 each) will perform a low-intensity aerobic training in cycle-ergometer, three times/week, for 45 minutes each session. Two control groups (gestational diabetes and chronic hypertension, n = 16 each) will perform an unique session/week of relaxation and stretching.

Outcomes: first ventilatory threshold, HbA1c,HOMA, type of delivery, weight and height of the newborn.

Detailed description: The statistical analysis will consist of:

* descriptive statistic;
* Levene's test
* Shapiro Wilk's normality test
* Parametric or non-parametric test
* a=0.05
* SPSS 17.0

Eligibility criteria: Inclusion Criteria:

* age \> 20 years;
* gestational age between 20 and 27 weeks (date of the last period and confirmed by ultrasound);
* Only one foetus in the womb;
* Without orthopedic limitations;
* Non-smoker;
* Medical clearance for exercise

Exclusion Criteria:

* Pre-eclampsia;
* fetal malformations;
* Intrauterine fetal death

Primary outcomes:
measure: glycated hemoglobin
timeFrame: day 1 and 10 weeks after training
Secondary outcomes:
measure: HOMA
timeFrame: day 1 and 10 weeks after training
Other outcomes:
measure: First ventilatory threshold
timeFrame: day 1 and 10 weeks after training
Locations:
city: Porto Alegre
country: Brazil
facility: Hospital de Clínicas de Porto Alegre
state: RS
Study officials:
affiliation: HC Porto Alegre
name: José Geraldo L Ramos, MD
role: PRINCIPAL_INVESTIGATOR
References: